BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
MET
MetLife, Inc.
MET has a slight edge over BAC overall, supported by stronger valuation.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
MET Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
MET's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MET.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over MET in the historical PE scenario, which offers more potential upside but is not a forecast.
MET PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $61.38 | -40% |
| Forward | 9.4x | $102 | — |
| Current | 13x | $102 | — |
| Fair | 15x | $115 | +13% |
| Expensive | 25x | $191 | +88% |
Historical ranges are pointers, not guarantees.
MET's PE is in its fair range at 13x. If earnings grow as analysts expect, today's price would be 9.4x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over MET on the outlook, with more favorable revenue expectations.
MET Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect MET's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
MET Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.87 | +42% |
| Q3 2026 | $7.68 | +45% |
| Q2 2026 | $5.23 | -11% |
| Q1 2026 | $5.17 | -16% |
| Q4 2025 | $4.71 | -21% |
| Q3 2025 | $5.28 | +6.5% |
| Q2 2025 | $5.87 | +58% |
| Q1 2025 | $6.12 | +110% |
| Q4 2024 | $5.94 | +225% |
MET earned $7.68 per share over the past year, up 45% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over MET on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over MET on profitability, with a higher operating margin.
MET Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.5B | +18% |
| Q2 2026 | $19.2B | +10% |
| Q1 2026 | $19.1B | +2.7% |
| Q4 2025 | $23.8B | +28% |
| Q3 2025 | $17.4B | -5.9% |
| Q2 2025 | $17.3B | -2.7% |
| Q1 2025 | $18.6B | +16% |
| Q4 2024 | $18.7B | -1.9% |
MET's revenue has grown year over year for four quarters in a row: $20.5B last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.9% | -0.6 points |
| Q2 2026 | 8.4% | +0.3 points |
| Q1 2026 | 8.6% | +0.9 points |
| Q4 2025 | 7% | -0.4 points |
| Q3 2025 | 9.5% | -1.3 points |
| Q2 2025 | 8% | +1.3 points |
| Q1 2025 | 7.6% | +1.1 points |
| Q4 2024 | 7.4% | +2.5 points |
MET's operating margin was 8.9% last quarter, down 0.6 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over MET on cash flow, with more consistent year-over-year improvement.
MET Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2B | -44% |
| Q2 2026 | $2.2B | +1.9% |
| Q1 2026 | $2.7B | -37% |
| Q4 2025 | $7.1B | +53% |
| Q3 2025 | $3.6B | -14% |
| Q2 2025 | $2.2B | -37% |
| Q1 2025 | $4.3B | +83% |
| Q4 2024 | $4.6B | -11% |
MET's free cash flow was $14B over the past year, down 4.3% from the year before. Free cash flow isn't a meaningful measure for financial services companies like MET.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over MET on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
MET Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -7M shares |
| 1 year | -4.4% | -29.2M shares |
| 3 years | -15% | -116M shares |
| 5 years | -26% | -221M shares |
| Available history | -32% | -305M shares |
MET has 640M diluted shares, down 4.4% from a year ago, with $2.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $651M |
| Q2 2026 | $722M |
| Q1 2026 | $755M |
| Q4 2025 | $460M |
| Q3 2025 | $502M |
| Q2 2025 | $510M |
| Q1 2025 | $1.4B |
| Q4 2024 | $406M |
MET spent $2.6B buying back its own shares over the past year, down 8.5% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
MET Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.1x | Net Cash |
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -2.6x | Net Cash |
| Q4 2025 | -2.8x | Net Cash |
| Q3 2025 | -2.6x | Net Cash |
| Q2 2025 | -2.7x | Net Cash |
| Q1 2025 | -2.7x | Net Cash |
| Q4 2024 | -3.3x | Net Cash |
MET has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
MET Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.6 | Neutral |
| Stochastic | 58.9 | Neutral |
MET's weekly RSI is 66 (neutral) and its Stochastic is 59 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over MET on valuation relative to its sector.
MET PE vs Financial Services Sector
| Metric | MET | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 1.8% above |
| PE % | 41 | 63 | 22 pts below |
MET is trading at 13x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
MET Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $98.8 | 3.1% above |
| 20 week MA | $96.8 | 5.3% above |
| 50 week MA | $85.6 | 19% above |
| 100 week MA | $82.5 | 23% above |
| 200 week MA | $75.3 | 35% above |
MET has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
MET Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.8 | $46.3 | -8.9% |
| 2021 | $46.3 | $61.8 | +33% |
| 2022 | $61.8 | $72.3 | +17% |
| 2023 | $72.3 | $66.1 | -8.5% |
| 2024 | $66.1 | $82.3 | +24% |
| 2025 | $82.3 | $80.3 | -2.4% |
| 2026 YTD | $80.3 | $101.9 | +27% |
MET has the edge over BAC on returns for 2026, with the stronger performance.